Nektar Therapeutics
NKTR
#4629
Rank
S$2.61 B
Marketcap
S$91.20
Share price
-1.54%
Change (1 day)
468.83%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$5.56

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$5.44. In 2024 the company made an earnings per share (EPS) of S-$4.50 an increase over its 2023 EPS that were of S-$28.14.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$5.5623.62%
2024S-$4.50-84.02%
2023S-$28.14-25.89%
2022S-$37.97-31.12%
2021S-$55.1314.86%
2020S-$48.00-1.19%
2019S-$48.58-163.96%
2018S$75.95-725.4%
2017S-$12.14-42.73%
2016S-$21.2083.33%
2015S-$11.5739.53%
2014S-$8.29-69.29%
2013S-$26.99-6.67%
2012S-$28.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.31-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.75-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.42-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$2.38-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.39-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$7.62-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.08995-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.66-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland